PMID

Data

Article Title

Organization

Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2.

Imclone Systems

Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitors.

Imclone Systems

Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase.

Imclone Systems

Tricyclic azepine derivatives: pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors.

Imclone Systems

Arylphthalazines. Part 2: 1-(Isoquinolin-5-yl)-4-arylamino phthalazines as potent inhibitors of VEGF receptors I and II.

Imclone Systems

1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors.

Imclone Systems

N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors.

Imclone Systems

Pyrimido-oxazepine as a versatile template for the development of inhibitors of specific kinases.

Imclone Systems

Arylphthalazines: identification of a new phthalazine chemotype as inhibitors of VEGFR kinase.

Imclone Systems